- 24 h
- 7 Tage
- 14 Tage
- 6 Monate
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 05:18 | Merck close to $6B acquisition of Terns Pharma to boost cancer portfolio: FT | 2 | Seeking Alpha | ||
| 05:18 | CSPC PHARMA (01093): CASH DIVIDEND ANNOUNCEMENT FOR EQUITY ISSUER | 1 | HKEx | ||
| 05:16 | CSPC PHARMA (01093): ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2025 | 2 | HKEx | ||
| 05:10 | Ölpreise verunsichern Börsen - LifeScience rückt in den Fokus! Bayer, Vidac Pharma, Valneva, Novo Nordisk und Pfizer mit heißen News | 175 | inv3st.de | Die Auseinandersetzungen im Nahen Osten gehen weiter. Mit den ersten Gesprächen zwischen USA und dem Iran vollzogen die Börsen eine Blitz-Anpassung nach oben. So konnte der deutsche Leit-Index DAX 40... ► Artikel lesen | |
| 05:01 | UNITED LAB (03933): PROGRESS IN CLINICAL TRIAL OF THE GROUP'S PRODUCT UBT251 INJECTION | 2 | HKEx | ||
| 04:45 | Pharma Stocks: Cipla, Lupin, Sun Pharma - Where is upside and who faces downside in GLP-1 boom? | 1 | ZEE Business | ||
| 04:29 | SYNTARA LIMITED: NWR Virtual Healthcare Conference Presentation | 2 | ASX | ||
| 04:17 | CHINARES PHARMA Surges 10%+ Near 250MA; 2025 Profit Up 21% w/Final DPS Up 1.3x+ | 1 | AASTOCKS | ||
| 03:50 | Clarity Pharma Secures Key Supply Deal to Boost Commercialisation of Prostate Cancer Agent | 1 | smallcaps.com.au | ||
| 03:35 | Merck nears $6 billion acquisition of Terns Pharma to boost cancer portfolio, FT reports | 6 | Reuters | ||
| 03:26 | Daily Special: 4DMedical, Carnaby Resources, Clarity Pharmaceuticals | 1 | Finance News Network | ||
| 03:10 | Wednesday's HotCopper trends: Clarity Pharma, Amplitude, 4DX, and other daily topics | March 25 | 1 | The Market Herald Australia | ||
| 03:05 | Clarity Pharmaceuticals shares are up 12% today. Here's what's driving the move | 2 | The Motley Fool Australia | ||
| 02:47 | INNOVENT BIO-Eli Lilly Strategic Collaboration Deal Takes Effect; Rumored Acquisition Intent Not True | 4 | AASTOCKS | ||
| 02:30 | BioSyent Inc: BioSyent grants 44,222 RSUs | 1 | Stockwatch | ||
| 02:17 | CHINARES PHARMA's Annual NP Spikes 21% to RMB4.045B; Final Div. RMB0.122 | 3 | AASTOCKS | ||
| 01:54 | Numinus Wellness Inc: Numinus shares to be delisted from TSX April 22 | 2 | Stockwatch | ||
| 01:54 | XORTX Therapeutics Inc (3): XORTX Therapeutics shareholders approve 1:10 rollback | 1 | Stockwatch | ||
| 01:18 | Cannabist Company Holdings Inc (The): Cannabist to sell businesses, starts CCAA proceedings | 1 | Stockwatch | ||
| 01:12 | MAYNE PHARMA GROUP LIMITED: Mayne Pharma ASX SMIDcaps conference presentation | 1 | ASX |
1 2 3 4 5 Weiter >>
- 24 h
- 7 Tage
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | Aktuelle Nachrichten | |||
|---|---|---|---|---|---|---|---|
| BAYER | 24 | 36 | -1,88 % | EQS-News: Formycon AG: Formycon sichert Vermarktungsstart für Aflibercept-2mg-Biosimilar FYB203 in Europa und weiteren Territorien durch Settlement mit Regeneron und Bayer | EQS-News: Formycon AG
/ Schlagwort(e): Sonstiges
Formycon sichert Vermarktungsstart für Aflibercept-2mg-Biosimilar FYB203 in Europa und weiteren Territorien durch Settlement mit... ► Artikel lesen | ||
| GILEAD SCIENCES | 17 | 5 | -1,20 % | Gilead mit Doppelschlag | Zwei milliardenschwere Übernahmen in einem Monat: Die Biotech-Gesellschaft Gilead bleibt äußerst aktiv in Sachen M&A. Nachdem die Amerikaner bereits am 23. Februar die Akquisition des Partners Arcellx... ► Artikel lesen | ||
 | NOVO NORDISK | 9 | 40 | -0,23 % | Eli Lilly: Analyst warnt - auch Novo Nordisk fällt | Kräftig nach unten ging es am Dienstag bei der Aktie von Eli Lilly. Mit einem Minus von fast sechs Prozent gehörte das Papier zu den stärksten Verlierern des Tages im S&P 500. Auch die Aktie von Novo... ► Artikel lesen | |
| ACHIEVE LIFE SCIENCES | 8 | - | -2,89 % | Achieve Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates | Achieve also Announces Partnership with U.S.-based Adare Pharma Solutions for Cytisinicline Manufacturing Conference Call Scheduled for 8:30 AM EDT Today, March 24, 2026 SEATTLE and VANCOUVER, British... ► Artikel lesen | ||
| LIVZON | 8 | - | -1,40 % | Livzon Pharmaceutical Group Inc. Full Year Sales Increase | |||
| VERTICAL AEROSPACE | 8 | - | -6,77 % | Vertical Aerospace Advances Piloted Flight Testing, Manufacturing and Demand for Valo | Valo launched, driving renewed customer and partner demand
Significant piloted flight phases completed; transition testing underway
Manufacturing expansion supports early production... ► Artikel lesen | ||
| GENERATE BIOMEDICINES | 8 | - | -3,06 % | Generate Biomedicines gains buy initiations from Guggenheim, Piper Sandler | |||
| COMPASS PATHWAYS | 7 | 11 | -1,32 % | Compass Pathfinder Limited: Compass Pathways Announces Fourth Quarter and Full-Year 2025 Financial Results and Business Highlights | COMP360 is the first classic psychedelic1 to consistently achieve a highly statistically significant result and clinically meaningful effect in treatment resistant depression (TRD), with a generally... ► Artikel lesen | ||
| HARROW | 7 | 4 | +3,50 % | Harrow prices $50 million debt offering at 8.625% due 2030 | |||
| NEUROGENE | 7 | 1 | +5,89 % | Neurogene Inc. - S-8, Securities to be offered to employees in employee benefit plans |
- Alle
| Unternehmen / Aktien | Aktueller Kurs | Ø Kursziel (Euro) | Potential (Euro) | kaufen | halten | verkaufen | |||
|---|---|---|---|---|---|---|---|---|---|
| DOCMORRIS AG | 4,350 | 7,37 | +70 % | 6 | 9 | 4 | |||
| SCHOTT PHARMA AG & CO KGAA | 13,300 | 18,70 | +41 % | 3 | 10 | - | |||
| MERCK KGAA | 103,35 | 141,60 | +37 % | 12 | 8 | - | |||
| ELI LILLY AND COMPANY | 781,10 | 968,78 | +24 % | 1 | - | - | |||
| SANOFI SA | 77,94 | 94,57 | +21 % | 10 | 14 | - | |||
| ASTRAZENECA PLC | 160,05 | 190,53 | +19 % | 20 | 1 | 5 | |||
| NOVO NORDISK A/S | 31,870 | 37,42 | +17 % | 17 | 24 | 3 | ||
| BAYER AG | 37,740 | 41,71 | +11 % | 25 | 11 | 1 | |||
| PFIZER INC | 23,310 | 23,93 | +3 % | 1 | 5 | - | |||
| NOVARTIS AG | 127,36 | 129,55 | +2 % | 6 | 13 | 3 | |||
| GSK PLC | 22,810 | 22,79 | 0 % | 4 | 11 | 13 | |||
| DERMAPHARM HOLDING SE | 41,800 | 34 | -19 % | - | 1 | - |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.